Is there a rationale for therapeutic immunoadsorption in multiple sclerosis?
Berger
Thomas
T
Innsbruck Medical University, Innsbruck, Austria.
D000906:Antibodies / Q000276:immunology; D002490:Central Nervous System / Q000276:immunology; D006801:Humans; D007163:Immunosorbent Techniques; D009103:Multiple Sclerosis / Q000276:immunology* / Q000628:therapy; D009185:Myelin Proteins; D009186:Myelin Sheath; D018992:Myelin-Associated Glycoprotein / Q000276:immunology; D063308:Myelin-Oligodendrocyte Glycoprotein
D000906:Antibodies; C571326:MOG protein, human; D009185:Myelin Proteins; D018992:Myelin-Associated Glycoprotein; D063308:Myelin-Oligodendrocyte Glycoprotein